Your browser doesn't support javascript.
loading
Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma.
Pinkerton, James W; Kim, Richard Y; Brown, Alexandra C; Rae, Brittany E; Donovan, Chantal; Mayall, Jemma R; Carroll, Olivia R; Khadem Ali, Md; Scott, Hayley A; Berthon, Bronwyn S; Baines, Katherine J; Starkey, Malcolm R; Kermani, Nazanin Z; Guo, Yi-Ke; Robertson, Avril A B; O'Neill, Luke A J; Adcock, Ian M; Cooper, Matthew A; Gibson, Peter G; Wood, Lisa G; Hansbro, Philip M; Horvat, Jay C.
Afiliação
  • Pinkerton JW; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
  • Kim RY; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia.
  • Brown AC; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Rae BE; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Donovan C; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia.
  • Mayall JR; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Carroll OR; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Khadem Ali M; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, Calif.
  • Scott HA; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Berthon BS; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Baines KJ; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Starkey MR; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Priority Research Centre GrowUpWell, Hunter Medical Research Inst
  • Kermani NZ; Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom.
  • Guo YK; Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom.
  • Robertson AAB; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.
  • O'Neill LAJ; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Adcock IM; Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
  • Cooper MA; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
  • Gibson PG; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Wood LG; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Hansbro PM; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia.
  • Horvat JC; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia. Electronic address: Jay.horvat@newcastle.edu.au.
J Allergy Clin Immunol ; 149(4): 1270-1280, 2022 04.
Article em En | MEDLINE | ID: mdl-34678326
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Inflamassomos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Inflamassomos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido